High-signal headlines only - macro events, earnings, M&A, regulatory. Listicles and analyst clickbait filtered out by default. Refreshed hourly.
The U.S. Army selected five companies to build nuclear microreactors at military bases, with the first one switching on as soon as September 2028.
Trump’s Saudi nuclear deal is now before Congress and could create new opportunities for U.S. companies involved in uranium, enrichment, reactors and nuclear fuel.
BWX Technologies deepens its government services role through national laboratory management, adding long-term facility operations to its portfolio.
Cathie Wood's ARK Invest made big buys of SpaceX stock across multiple ETFs on Friday. SpaceX is firm's second-largest investment, behind only Tesla.
A number of stocks fell in the afternoon session after the White House pivoted its Iran strategy toward financial sanctions, signaling a de-escalation of military options. President Donald Trump announced the U.S. will launch "Economic Warfare and Isolation on an unprecedented scale" against Iran, CNBC reported.
BWX Technologies has delivered a strong 197.6% gain over the past 5 years, yet its current checks suggest the stock may now be priced at a premium compared with its estimated intrinsic value. At the same time, BWX Technologies is involved in high profile nuclear fuel and enrichment projects that many investors view as important long term drivers. Over 5 years, BWX Technologies has returned 197.6%, which puts extra focus on whether recent gains already reflect its long term cash flow...
BWX Technologies (BWXT) drew fresh attention after Clean Core Thorium Energy chose its Kinectrics division to perform an independent technical review of the ANEEL fuel qualification program ahead of a potential commercial reactor demonstration. See our latest analysis for BWX Technologies. For context, BWX Technologies' share price has eased in the short term, with a 1-day share price return of 1.67% decline and a 90-day share price return of 19.88% decline. Even though the 5-year total...
NuScale just posted quarterly revenue that would embarrass a lemonade stand, yet the company holds something no other SMR developer in America can claim. Here is what that paradox means for investors weighing a stock already down sharply this year.
Free cash flow is one of the most reliable indicators of financial durability. These businesses not only generate cash but reinvest intelligently to sustain momentum.
BWX Technologies expands its nuclear services portfolio through decommissioning, remediation, waste management and nuclear site support.
BWXT expands its commercial nuclear portfolio through nuclear medicine, isotope production and radiopharmaceutical capabilities.
BWX's second quarter performance reflected robust demand across both its government and commercial nuclear businesses, with revenue growth led by increased activity in commercial nuclear power and aftermarket services. Management pointed to strong operational execution and productivity improvements, particularly in Government Operations, as key contributors. CEO Rex Geveden highlighted the company's “position of strength with exposure across the nuclear value chain,” and noted that the recent sa
Babcock (NYSE:BW) reported higher second-quarter revenue, net income and adjusted EBITDA, citing increased project activity and demand for reliable power generation from utility, industrial and data center customers. Chairman and Chief Executive Officer Kenny Young said the company raised its full-
Commercial nuclear revenue surged 72% as management raised full-year guidance.
One turnaround story bleeds cash while the other generates it steadily. The valuation gap between them tells an important story about risk and reward.
Congresswoman April McClain Delaney recently disclosed up to $1.4 million worth of new stock trades. Wall Street is paying attention because she sits on the House Science, Space, and Technology Committee. BWX Technologies, Inc. (NYSE:BWXT) and Entegris, Inc. (NASDAQ:ENTG) are among the top buys in the politician’s portfolio that are getting limelight. Let’s look at […]
Hyperscalers are signing decade-long power deals that would have seemed absurd three years ago, and three nuclear stocks sit at the center of that shift as an operator, a fuel producer, and a components maker each tell a very different story about risk and reward.
BWX Technologies, Inc. reported past Q2 2026 results with sales of US$901.63 million and net income of US$89.01 million, raised full‑year 2026 revenue guidance to about US$3.80 billion, and its board declared a US$0.27 per‑share quarterly dividend payable on September 4, 2026. At the same time, BWX Technologies agreed to sell most of its medical business for up to US$800 million, sharpening its focus on core nuclear markets and advanced reactor technologies. We’ll now examine how the raised...
BWXT raises its 2026 outlook as stronger operations support higher guidance, while a medical divestiture and PCG deal sharpen its nuclear focus.
BWX Technologies (NYSE:BWXT) has agreed to sell its medical business to Nordic Capital, while keeping a minority interest and technical involvement. The company has also signed a fuel fabrication agreement with Clean Core Thorium Energy related to future nuclear fuel deployments. These moves indicate a shift in BWX Technologies’ business mix toward core nuclear operations and advanced fuel capabilities. BWX Technologies enters these transactions with a share price of $173.79 and a 5 year...
Moby summary of BWX Technologies, Inc.'s Q2 2026 earnings call
BWXT posts 18% revenue growth, raises full-year guidance, and sharpens focus on nuclear core markets with $800 million medical business sale.
BWX Technologies (NYSE:BWXT) reported second-quarter 2026 revenue growth of 18% and raised its full-year financial outlook, citing continued demand across nuclear national security and commercial power markets. Second-quarter revenue reached $902 million, including 9% organic growth, while adjusted
BWX (BWXT) delivered earnings and revenue surprises of +5.94% and +1.10%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?
Aerospace and defense company BWX (NYSE:BWXT) met Wall Street’s revenue expectations in Q2 CY2026, with sales up 18% year on year to $901.6 million. Its non-GAAP profit of $1.07 per share was 2.7% above analysts’ consensus estimates.
Aerospace and defense company BWX (NYSE:BWXT) will be reporting earnings this Monday afternoon. Here’s what to expect.
Companies that consistently increase their sales, margins, or returns on capital are usually rewarded with the best returns, and those that can do all three for years on end are almost always the legendary stocks that return 100 times your money.
Westinghouse Electric says it plans to start construction on 10 new reactors in the U.S. by 2030. Its IPO could be a blockbuster.
BWXT heads into Q2 with nuclear, medical and defense demand supporting sales, while earnings are expected to edge lower.
We use Google Analytics to count anonymous page views and understand which content gets read. No ads, no profiles. Decline keeps you on cookieless mode. Details.
